miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes

miR-205 Expression Levels in Nonsmall Cell Lung CancerDo Not Always Distinguish Adenocarcinomas From Squamous Cell Carcinomas

(2011) Valerio Del Vescovo et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Systematic Evaluation of Three microRNA Profiling Platforms: Microarray, Beads Array, and Quantitative Real-Time PCR Array

(2011) Bin Wang et al.   PLoS One

MicroRNA Expression in Induced Sputum of Smokers and Patients with Chronic Obstructive Pulmonary Disease

(2010) Geert R. Van Pottelberge et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer

(2010) Shahana Majid et al.   CANCER

Dietary methyl donors, methyl metabolizing enzymes, and epigenetic regulators: diet–gene interactions and promoter CpG island hypermethylation in colorectal cancer

(2010) Stefan de Vogel et al.   CANCER CAUSES & CONTROL

MicroRNAs and cancer: An overview

(2010) Pedro P. Medina et al.   CELL CYCLE

MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer

(2010) M. T. Landi et al.   CLINICAL CANCER RESEARCH

Accurate Classification of Non-Small Cell Lung Carcinoma Using a Novel MicroRNA-Based Approach

(2010) J. A. Bishop et al.   CLINICAL CANCER RESEARCH

The Prognostic and Predictive Role of Histology in Advanced Non-small Cell Lung Cancer: A Literature Review

(2010) Fred R. Hirsch et al.   Journal of Thoracic Oncology

Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers

(2010) Lingxiao Xing et al.   MODERN PATHOLOGY

Specific Alterations of MicroRNA Transcriptome and Global Network Structure in Colorectal Carcinoma after Cetuximab Treatment

(2010) M. Ragusa et al.   MOLECULAR CANCER THERAPEUTICS

P63 differentiates subtypes of nonsmall cell carcinomas of lung in cytologic samples

(2009) Merce Jorda et al.   CANCER CYTOPATHOLOGY

MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer

(2009) M. Raponi et al.   CANCER RESEARCH

Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells

(2009) Y. Li et al.   CANCER RESEARCH

Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma

(2009) Danit Lebanony et al.   JOURNAL OF CLINICAL ONCOLOGY

MicroRNA Signature Predicts Survival and Relapse in Lung Cancer

(2008) Sung-Liang Yu et al.   CANCER CELL

Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke

(2008) Alberto Izzotti et al.   FASEB JOURNAL

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

(2008) Giorgio Vittorio Scagliotti et al.   JOURNAL OF CLINICAL ONCOLOGY

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

(2008) Philip A. Gregory et al.   NATURE CELL BIOLOGY